These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 37302347)
1. USP39-mediated deubiquitination of Cyclin B1 promotes tumor cell proliferation and glioma progression. Xiao Y; Chen X; Hu W; Ma W; Di Q; Tang H; Zhao X; Huang G; Chen W Transl Oncol; 2023 Aug; 34():101713. PubMed ID: 37302347 [TBL] [Abstract][Full Text] [Related]
2. USP39 mediates p21-dependent proliferation and neoplasia of colon cancer cells by regulating the p53/p21/CDC2/cyclin B1 axis. Yuan J; Li X; Zhang G; Cheng W; Wang W; Lei Y; Ma Q; Song G Mol Carcinog; 2021 Apr; 60(4):265-278. PubMed ID: 33634905 [TBL] [Abstract][Full Text] [Related]
3. USP39 facilitates breast cancer cell proliferation through stabilization of FOXM1. Zhang Z; Liu W; Bao X; Sun T; Wang J; Li M; Liu C Am J Cancer Res; 2022; 12(8):3644-3661. PubMed ID: 36119839 [TBL] [Abstract][Full Text] [Related]
4. USP39 promotes ovarian cancer malignant phenotypes and carboplatin chemoresistance. Wang L; Chen T; Li X; Yan W; Lou Y; Liu Z; Chen H; Cui Z Int J Oncol; 2019 Jul; 55(1):277-288. PubMed ID: 31180526 [TBL] [Abstract][Full Text] [Related]
5. USP39 promotes the growth of human hepatocellular carcinoma in vitro and in vivo. Yuan X; Sun X; Shi X; Jiang C; Yu D; Zhang W; Guan W; Zhou J; Wu Y; Qiu Y; Ding Y